Channel Futures is part of the Knowledge & Networking Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Research Library

The top resource for free research, white papers, reports, case studies, magazines, and eBooks.

Share Your Content with Us
on TradePub.com for readers like you. LEARN MORE
Chronic Obstructive Pulmonary Disease- Pipeline Analysis 2018
Request Your Free Research Report Now:

"Chronic Obstructive Pulmonary Disease- Pipeline Analysis 2018"
Request

There are total 141 molecules in pipeline (Company Molecules 90, University & Institute Molecules 51) in different phases of development.

There are total 141 molecules in pipeline (Company Molecules 90, University & Institute Molecules 51) in different phases of development. As per GervanoRA Pipeline Analysis, One molecule is expected to get regulatory approval in 2018; three molecules are expected get regulatory approvals in 2019 and nine molecules in 2020.  Report provides comprehensive information on the therapeutics under development for COPD with analysis by stage of development, drug class, mechanism of action (MoA), route of administration (RoA), geography and developers (Companies, Universities and Institutes).


Offered Free by: GervanoRA Data Services
See All Resources from: GervanoRA Data Services

Request

Recommended for Professionals Like You: